Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_assertion type Assertion NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_head.
- NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_assertion wasGeneratedBy ECO_0000203 NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_provenance.
- NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_assertion wasDerivedFrom befree-20140225 NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_provenance.
- NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_assertion SIO_000772 20142599 NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_provenance.
- NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_assertion evidence source_evidence_literature NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_provenance.
- NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_assertion description "[Because p53 immunopositivity is an adverse prognostic marker in pediatric medulloblastoma and TP53 mutations are associated with chemotherapy and radiation therapy resistance, we aimed to determine the extent and role of TP53 mutations in pediatric medulloblastoma treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_provenance.